Literature DB >> 22323536

E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages.

Wei Zhao1, Lijuan Wang, Meng Zhang, Chao Yuan, Chengjiang Gao.   

Abstract

Activation of TLR signaling in the innate immune cells is critical for the elimination of invading microorganisms. However, uncontrolled activation may lead to autoimmune and inflammatory diseases. In this article, we report the identification of tripartite motif (TRIM) 38 as a negative feedback regulator in TLR signaling by targeting TNFR-associated factor 6 (TRAF6). TRIM38 was induced by TLR stimulation in an NF-κB-dependent manner in macrophages. Knockdown of TRIM38 expression by small interfering RNA resulted in augmented activation of NF-κB and MAPKs, and enhanced expression of proinflammatory cytokines, whereas overexpression of TRIM38 has an opposite effect. As an E3 ligase, TRIM38 bound to TRAF6 and promoted K48-linked polyubiquitination, which led to the proteasomal degradation of TRAF6. Consistently, knockdown of TRIM38 expression resulted in higher protein level of TRAF6 in primary macrophages. Our findings defined a novel function for TRIM38 to prevent excessive TLR-induced inflammatory responses through proteasomal degradation of TRAF6.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323536     DOI: 10.4049/jimmunol.1103255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors.

Authors:  Gijs A Versteeg; Ricardo Rajsbaum; Maria Teresa Sánchez-Aparicio; Ana M Maestre; Julio Valdiviezo; Mude Shi; Kyung-Soo Inn; Ana Fernandez-Sesma; Jae Jung; Adolfo García-Sastre
Journal:  Immunity       Date:  2013-02-21       Impact factor: 31.745

Review 2.  Multifaceted roles of TRIM38 in innate immune and inflammatory responses.

Authors:  Ming-Ming Hu; Hong-Bing Shu
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

3.  TRIM dsDNA sensor to restrict innate immune response.

Authors:  Zhijian Cai; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

Review 4.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

Review 5.  Ubiquitination in the antiviral immune response.

Authors:  Meredith E Davis; Michaela U Gack
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

Review 6.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

7.  USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I.

Authors:  Lijuan Wang; Wei Zhao; Meng Zhang; Peng Wang; Kai Zhao; Xueying Zhao; Shangru Yang; Chengjiang Gao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.

Authors:  Ming-Ming Hu; Qing Yang; Jing Zhang; Shi-Meng Liu; Yu Zhang; Heng Lin; Zhe-Fu Huang; Yan-Yi Wang; Xiao-Dong Zhang; Bo Zhong; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

9.  The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA.

Authors:  Zhiqiang Zhang; Musheng Bao; Ning Lu; Leiyun Weng; Bin Yuan; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2012-12-09       Impact factor: 25.606

10.  Carboxyl terminus of Hsp70-interacting protein regulation of osteoclast formation in mice through promotion of tumor necrosis factor receptor-associated factor 6 protein degradation.

Authors:  Shan Li; Bing Shu; Yanquan Zhang; Jia Li; Junwei Guo; Yinyin Wang; Fangli Ren; Guozhi Xiao; Zhijie Chang; Di Chen
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.